IQVIA HOLDINGS INC. Revenue
IQVIA HOLDINGS INC. (IQV) reported Revenue of $4.15 billion for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-05-05
- IQVIA HOLDINGS INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $4.15B, a 8.41% increase year-over-year.
- IQVIA HOLDINGS INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $4.36B, a 10.26% increase year-over-year.
- IQVIA HOLDINGS INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $4.10B, a 5.24% increase year-over-year.
- IQVIA HOLDINGS INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-06-30 was $4.02B, a 5.32% increase year-over-year.
- IQVIA HOLDINGS INC. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $16.31B, a 5.87% increase from fiscal 2024.
- IQVIA HOLDINGS INC. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $15.40B, a 2.81% increase from fiscal 2023.
- IQVIA HOLDINGS INC. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $14.98B, a 3.98% increase from fiscal 2022.
- IQVIA HOLDINGS INC. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $14.41B, a 3.86% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-03-31 | $4.15B 10-Q · filed 2026-05-05 | $8.52B derived: sum of 2 quarters · filed 2026-05-05 | $12.62B derived: sum of 3 quarters · filed 2026-05-05 | $16.63B derived: sum of 4 quarters · filed 2026-05-05 |
| 2025-12-31 | $4.36B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $8.46B derived: sum of 2 quarters · filed 2026-02-17 | $12.48B derived: sum of 3 quarters · filed 2026-02-17 | $16.31B 10-K · filed 2026-02-17 |
| 2025-09-30 | $4.10B 10-Q · filed 2025-10-28 | $8.12B derived: sum of 2 quarters · filed 2025-10-28 | $11.95B 10-Q · filed 2025-10-28 | $15.90B derived: sum of 4 quarters · filed 2026-05-05 |
| 2025-06-30 | $4.02B 10-Q · filed 2025-07-22 | $7.85B 10-Q · filed 2025-07-22 | $11.80B derived: sum of 3 quarters · filed 2026-05-05 | $15.70B derived: sum of 4 quarters · filed 2026-05-05 |
| 2025-03-31 | $3.83B 10-Q · filed 2026-05-05 | $7.79B derived: sum of 2 quarters · filed 2026-05-05 | $11.68B derived: sum of 3 quarters · filed 2026-05-05 | $15.50B derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $3.96B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $7.85B derived: sum of 2 quarters · filed 2026-02-17 | $11.67B derived: sum of 3 quarters · filed 2026-02-17 | $15.40B 10-K · filed 2026-02-17 |
| 2024-09-30 | $3.90B 10-Q · filed 2025-10-28 | $7.71B derived: sum of 2 quarters · filed 2025-10-28 | $11.45B 10-Q · filed 2025-10-28 | $15.31B derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $3.81B 10-Q · filed 2025-07-22 | $7.55B 10-Q · filed 2025-07-22 | $11.42B derived: sum of 3 quarters · filed 2026-02-17 | $15.15B derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $3.74B 10-Q · filed 2025-05-06 | $7.61B derived: sum of 2 quarters · filed 2026-02-17 | $11.34B derived: sum of 3 quarters · filed 2026-02-17 | $15.07B derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $3.87B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $7.60B derived: sum of 2 quarters · filed 2026-02-17 | $11.33B derived: sum of 3 quarters · filed 2026-02-17 | $14.98B 10-K · filed 2026-02-17 |
| 2023-09-30 | $3.74B 10-Q · filed 2024-10-31 | $7.46B derived: sum of 2 quarters · filed 2024-10-31 | $11.12B 10-Q · filed 2024-10-31 | $14.86B derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-06-30 | $3.73B 10-Q · filed 2024-07-22 | $7.38B 10-Q · filed 2024-07-22 | $11.12B derived: sum of 3 quarters · filed 2025-02-13 | $14.68B derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-03-31 | $3.65B 10-Q · filed 2024-05-02 | $7.39B derived: sum of 2 quarters · filed 2025-02-13 | $10.95B derived: sum of 3 quarters · filed 2025-02-13 | $14.49B derived: sum of 4 quarters · filed 2025-02-13 |
| 2022-12-31 | $3.74B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $7.30B derived: sum of 2 quarters · filed 2025-02-13 | $10.84B derived: sum of 3 quarters · filed 2025-02-13 | $14.41B 10-K · filed 2025-02-13 |
| 2022-09-30 | $3.56B 10-Q · filed 2023-11-01 | $7.10B derived: sum of 2 quarters · filed 2023-11-01 | $10.67B 10-Q · filed 2023-11-01 | $14.31B derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-06-30 | $3.54B 10-Q · filed 2023-08-01 | $7.11B 10-Q · filed 2023-08-01 | $10.74B derived: sum of 3 quarters · filed 2024-02-15 | $14.14B derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-03-31 | $3.57B 10-Q · filed 2023-04-28 | $7.20B derived: sum of 2 quarters · filed 2024-02-15 | $10.60B derived: sum of 3 quarters · filed 2024-02-15 | $14.03B derived: sum of 4 quarters · filed 2024-02-15 |
| 2021-12-31 | $3.64B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $7.03B derived: sum of 2 quarters · filed 2024-02-15 | $10.46B derived: sum of 3 quarters · filed 2024-02-15 | $13.87B 10-K · filed 2024-02-15 |
| 2021-09-30 | $3.39B 10-Q · filed 2022-10-27 | $6.83B derived: sum of 2 quarters · filed 2022-10-27 | $10.24B 10-Q · filed 2022-10-27 | $13.54B derived: sum of 4 quarters · filed 2022-10-27 |
| 2021-06-30 | $3.44B 10-Q · filed 2022-07-22 | $6.85B 10-Q · filed 2022-07-22 | $10.14B derived: sum of 3 quarters · filed 2022-07-22 | $12.93B derived: sum of 4 quarters · filed 2022-07-22 |
| 2021-03-31 | $3.41B 10-Q · filed 2022-04-28 | $6.71B derived: sum of 2 quarters · filed 2022-04-28 | $9.49B derived: sum of 3 quarters · filed 2022-04-28 | $12.01B derived: sum of 4 quarters · filed 2022-04-28 |
| 2020-12-31 | $3.30B 10-K · filed 2021-02-12 | $6.08B derived: sum of 2 quarters · filed 2021-10-22 | $8.61B derived: sum of 3 quarters · filed 2021-10-22 | $11.36B 10-K · filed 2023-02-15 |
| 2020-09-30 | $2.79B 10-Q · filed 2021-10-22 | $5.31B derived: sum of 2 quarters · filed 2021-10-22 | $8.06B 10-Q · filed 2021-10-22 | $10.96B derived: sum of 4 quarters · filed 2021-10-22 |
| 2020-06-30 | $2.52B 10-Q · filed 2021-07-28 | $5.28B 10-Q · filed 2021-07-28 | $8.17B derived: sum of 3 quarters · filed 2021-07-28 | $10.94B derived: sum of 4 quarters · filed 2021-07-28 |
| 2020-03-31 | $2.75B 10-Q · filed 2021-04-23 | $5.65B derived: sum of 2 quarters · filed 2021-04-23 | $8.42B derived: sum of 3 quarters · filed 2021-04-23 | $11.16B derived: sum of 4 quarters · filed 2021-04-23 |
| 2019-12-31 | $2.90B 10-K · filed 2021-02-12 | $5.66B derived: sum of 2 quarters · filed 2021-02-12 | $8.40B derived: sum of 3 quarters · filed 2021-02-12 | $11.09B 10-K · filed 2022-02-16 |
| 2019-09-30 | $2.77B 10-K · filed 2021-02-12 | $5.51B derived: sum of 2 quarters · filed 2021-02-12 | $8.19B 10-Q · filed 2020-10-22 | $10.88B derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-06-30 | $2.74B 10-K · filed 2021-02-12 | $5.42B 10-Q · filed 2020-07-23 | $8.11B derived: sum of 3 quarters · filed 2021-02-12 | $10.71B derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-03-31 | $2.68B 10-K · filed 2021-02-12 | $5.37B derived: sum of 2 quarters · filed 2021-02-12 | $7.97B derived: sum of 3 quarters · filed 2021-02-12 | $10.53B derived: sum of 4 quarters · filed 2021-02-12 |
| 2018-12-31 | $2.69B 10-K · filed 2020-02-18 | $5.28B derived: sum of 2 quarters · filed 2020-02-18 | $7.85B derived: sum of 3 quarters · filed 2020-02-18 | $10.41B 10-K · filed 2021-02-12 |
| 2018-09-30 | $2.59B 10-K · filed 2020-02-18 | $5.16B derived: sum of 2 quarters · filed 2020-02-18 | $7.72B 10-Q · filed 2019-11-01 | $10.24B derived: sum of 4 quarters · filed 2020-02-18 |
| 2018-06-30 | $2.57B 10-K · filed 2020-02-18 | $5.13B 10-Q · filed 2019-07-24 | $7.65B derived: sum of 3 quarters · filed 2020-02-18 | $10.12B derived: sum of 4 quarters · filed 2020-02-18 |
| 2018-03-31 | $2.56B 10-K · filed 2020-02-18 | $5.08B derived: sum of 2 quarters · filed 2020-02-18 | $7.55B derived: sum of 3 quarters · filed 2020-02-18 | $9.90B derived: sum of 4 quarters · filed 2020-02-18 |
| 2017-12-31 | $2.52B 10-K · filed 2019-02-19 | $4.99B derived: sum of 2 quarters · filed 2019-02-19 | $7.34B derived: sum of 3 quarters · filed 2019-02-19 | $9.70B 10-K · filed 2020-02-18 |
| 2017-09-30 | $2.47B 10-K · filed 2019-02-19 | $4.82B derived: sum of 2 quarters · filed 2019-02-19 | $7.18B 10-Q · filed 2018-10-25 | |
| 2017-06-30 | $2.35B 10-K · filed 2019-02-19 | $4.71B 10-Q · filed 2018-07-27 | ||
| 2017-03-31 | $2.36B 10-K · filed 2019-02-19 | |||
| 2016-12-31 | $6.82B 10-K · filed 2019-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |